Answers are grounded in this paper and cite their sources.
Introduction: Multidisciplinary team (MDT) management has become a cornerstone of contemporary breast cancer care, reflecting the shift toward individualized, biology-driven treatment strategies. Beyond traditional tumor-node-metastasis (TNM) staging, modern practice incorporates prognostic staging and molecular characteristics to tailor therapy. International evidence demonstrates that MDT-based decision-making improves treatment planning, survival, and quality of life. However, MDT standards and implementation vary across institutions in Türkiye. This study aimed to establish a national consensus on the principles and standards of breast cancer MDT meetings (Breast tumor boards”) to promote harmonized, high-quality care. Methods: A national consensus development committee (CDC) was convened in November 2024, comprising 11 experienced specialists across general surgery, medical oncology, radiation oncology, pathology, and radiology. CDC decided to propose 37 statements addressing diagnosis, treatment planning, decision-making, and patient information, which are integral in discussing cases in an MDT. A total of 151 experts from the above disciplines participated as panel members for further voting on the statements. Eligibility criteria for becoming a panel member required substantial clinical and academic experience in breast cancer management. Contributing panelists scored each statement online on a 1–5 Likert scale. Reaching a consensus was defined as ≥75% agreement (scores 4–5), while rejection required ≥50% disagreement (scores 1–2). Results: Panelists included general/breast surgeons (30%), medical oncologists (25%), radiation oncologists (23%), pathologists (11%), and radiologists (12%), predominantly from university and teaching hospitals. Consensus was achieved on most statements, with high, consistent agreement across disciplines. Strong support emerged for regular, structured MDT meetings, comprehensive documentation and pre-meeting data sharing, evidence-based, individualized treatment planning, and coordinated interdisciplinary communication. The proposal advocating routine patient attendance at MDT meetings was rejected by consensus. The panel did not reach a consensus on statements proposing repeated MDT review after each adjuvant treatment phase and presentation of interim follow-up results during neoadjuvant therapy. Conclusion: This consensus initiative demonstrates broad national support for standardized MDT-based breast cancer management in Türkiye. A consensus was reached for establishing structured MDT principles, including regular meetings, qualified participation, systematic documentation, and adherence to contemporary prognostic staging.
No takes yet. Share an insight, caveat, or question.
Günay et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: